VARSAL NAMED TO INC. 5000 FOR THE SECOND TIME

August 15, 2023 — Inc. magazine today revealed that Varsal is No. 3,562 on its annual Inc. 5000 list (httpss://www.inc.com/profile/varsal), the most prestigious ranking of the nation’s fastest-growing private companies.

“We’re truly honored to be recognized by Inc. Magazine and be a part of such an impressive list of companies making an impact in their respective industries,” says Don Wang, General Manager of Varsal. “We are proud to make the list for the second time, and have spent the last 30 years tirelessly building our technical capabilities to maximize the value we can provide to our customers in high end industrial and pharmaceutical chemicals and intermediates applications.”

The Inc. 5000 class of 2023 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. Among this year’s top 500 companies, the average median three-year revenue growth rate ticked up to an astonishing 2,238 percent. In all, this year’s Inc. 5000 companies have added 1,187,266 jobs to the economy over the past three years.

“Running a business has only gotten harder since the end of the pandemic,” says Inc. editor-in-chief Scott Omelianuk. “To make the Inc. 5000—with the fast growth that requires—is truly an accomplishment. Inc. is thrilled to honor the companies that are building our future.”

More information about the Inc. 5000 can be found at www.inc.com/inc5000.

Please contact us to see how we can help you with your intermediate needs!

Latest News

Signup For Our Newsletter

Get updates to the latest News from Varsal, LLC by signing up to our Newsletter.

Name(Required)
Privacy(Required)

Request a Quote

Tell Us About Your Requirements

Varsal provides specialty chemicals, pharmaceutical intermediates, and custom manufacturing solutions to customers across regulated and specialty industries. Use the form below to request pricing or discuss project-specific requirements.

For general questions or non-quote-related inquiries, please visit our Contact page. Or you may call us directly by clicking the call button.